FDA: Balloon angioplasty catheters can reach market via 510(k) route

09/13/2010 | Medical Devices Today

The FDA issued a ruling saying manufacturers of balloon-tipped coronary angioplasty catheters can bring these products to market via the 510(k) process, rather than the premarket approval procedure, effective Oct. 8. The move is in line with the agency's decision to reclassify percutaneous transluminal coronary angioplasty catheters from Class III to Class II devices with corresponding special requirements.

View Full Article in:

Medical Devices Today

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Associate Director, Compliance Business Partner I
Boehringer Ingelheim
Ridgefield, CT
European Sales Manager
SentreHEART, Inc.
Germany, Benelux, UK
REG AFFAIRS PROJ MGR - 1400000A7F
Abbott
San Jose, CA
SPECIALIST II SYSTEMS INTEGRATION - 140000033P
Abbott
Dallas, TX
Attorney
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD